 TUCSON, Ariz., Dec. 28, 2022 GLOBE NEWSWIRE -- HTG Molecular Diagnostics, Inc. Nasdaq: HTGM HTG, a life science company advancing precision medicine through its innovative transcriptome-wide profiling and advanced medicinal chemistry technology, provides here a summary of its second HTG Therapeutics key opinion leader KOL webinar: The Role of RNA Profiling in Drug Discovery and Analysis, hosted on Tuesday, December 13, 2022. 